 U.S. News & World Report | Bristol-Myers Executive Accused of Insider Trading Businessweek Bristol-Myers Squibb Co. (BMY) (BMY) executive Robert Ramnarine was charged with insider trading for making $311361 in illegal profit by buying stock options in three companies targeted for acquisition. The FBI arrested Ramnarine, 45, this morning, and ... Bristol-Myers Squibb executive charged with trading stocks of firms company ... Bristol-Myers suspends hepatitis C treatment study Bristol-Myers executive charged with insider trading |
Thursday, August 2, 2012
Bristol-Myers Executive Accused of Insider Trading - Businessweek
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment